🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📣 Read our new meta-analysis on JAMA Psychiatry jamanetwork.com/journals/jamap… investigating #GLP1RAs and mental health outcomes in people with T2DM and obesity - an important study led by Aureliane Pierret & Toby Pillinger

GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/4khzu1z Riccardo De Giorgi KCLDiabetesPsych

🔙 #tbt #MentalHealthAwarenessMonth 🚨Riccardo De Giorgi et al. from the University of Oxford present a thorough analysis of pre-clinical and clinical studies examining the role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in #mental disorders. nature.com/articles/s4422…

Wonderful: New meta-analytic evidence that GLP-1RAs improve mental health-related quality of life.

Most viewed this week from JAMA Psychiatry: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/4kqyZ5r

Most viewed this week from JAMA Psychiatry: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/43owISN

Most viewed this week from JAMA Psychiatry: GLP1-RA treatment for obesity and diabetes does not increase psychiatric adverse events compared to placebo and is linked to improvements in quality of life, emotional eating, and mental well-being. ja.ma/44Voqmu

Simvastatin added to escitalopram did not improve depressive symptoms in patients with major depressive disorder and obesity, although it reduced cholesterol and C-reactive protein levels. ja.ma/43Hi33P

#GLP1RAs were associated with improved #QualityOfLife metrics and #EmotionalEating behaviors among individuals with #overweight and #obesity. Institute of Psychiatry, Psychology & Neuroscience Guy's and St Thomas' Imperial Medicine University of Oxford Oxford Health NHS FT Riccardo De Giorgi Toby Pillinger endocrinologyadvisor.com/news/glp-1ras-…